About this Event
This panel will explore the inner workings of the Advisory Committee on Immunization Practices (ACIP), highlighting how scientific evidence, cost-effectiveness analyses, and stakeholder input are integrated into national vaccine policy. Experts with firsthand experience on the ACIP will share insights on the committee’s decision-making processes and current challenges.
The Advisory Committee on Immunization Practices (ACIP) plays a central role in shaping U.S. vaccine policy by issuing recommendations that influence clinical and public health practice. In this panel, former ACIP members and workgroup participants, including Dr. Kevin Alt, Veronica McNally, and Henry Bernstein, will discuss the structure and function of the ACIP and the role of diverse stakeholder input in shaping policy. Moderated by Dr. Abram Wagner, the session will begin with a brief overview of ACIP operations followed by a discussion of how scientific, economic, and societal factors converge in the committee’s deliberations. The panel will also address how ACIP navigates new challenges in a shifting political and public health landscape.
Learning objectives:
- Describe the role and structure of the ACIP in U.S. vaccine policy-making.
- Explain how the ACIP incorporates cost-effectiveness analyses and other forms of evidence into its decision-making.
- Identify the types of stakeholder input that influence ACIP recommendations.
- Discuss key challenges the ACIP faces in the current political and public health environment.